Review
Accepted on 11 Oct 2026
From ecDNA Structure to Tumor Immune Escape and Therapeutic Resistance: Evidence, Uncertainty, and Clinical Priorities
Frontiers in Oncology
39,440 Publications
volumes
Volume 16 - 2026
Case Report
Accepted on 11 Oct 2026
Multidisciplinary approach with stereotactic reirradiation to oligoprogressive spinal metastases from dedifferentiated osteosarcoma: a case report
Frontiers in Oncology
Review
Accepted on 11 Oct 2026
Evidence and Clinical Implications of Target Antigen Changes and Reassessment after ADC Therapy in Solid Tumors
Frontiers in Oncology
Original Research
Accepted on 11 Oct 2026
Impact of Consolidative HSCT after CAR T-Cell–Induced Remission in Pediatric Relapsed/Refractory B-ALL: A Single-Center Retrospective Cohort
Frontiers in Oncology
Perspective
Accepted on 11 Oct 2026
Lactylation-Mediated Remodeling of Spatial Immunometabolic Niches in Lung Cancer: Metabolic Origins, Cellular Interactions, and Molecular Mechanisms
Frontiers in Oncology
Original Research
Accepted on 11 Oct 2026
Respiratory adverse-event signals of four Bruton tyrosine kinase inhibitors: cross-database replication and temporal characterization in FAERS and JADER
Frontiers in Oncology
Correction
Accepted on 11 Oct 2026
Correction: Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer
Frontiers in Oncology
Original Research
Accepted on 11 Oct 2026
COL1A2 Expression Is Associated with Prognosis, Stromal Remodeling, and Predicted Immunotherapy Response in Gastric Cancer
Frontiers in Oncology
Original Research
Accepted on 11 Oct 2026
Event-log reconstruction of the colorectal cancer screening pathway in Northern Portugal: an observational process-mining study
Frontiers in Oncology
Case Report
Accepted on 11 Oct 2026
Renal autotransplantation for pheochromocytoma involving the renal hilar vessels with kidney preservation: a case report and literature review
Frontiers in Oncology
General Commentary
Accepted on 11 Oct 2026
Commentary: Case Report: Experience of a rare case of primary acute mast cell leukemia with FGFR1 gene rearrangement
Frontiers in Oncology
Original Research
Accepted on 11 Oct 2026
PF chemotherapy combined with a PD-1/CTLA-4 bispecific antibody as first-line treatment in patients with recurrent/metastatic head and neck squamous cell carcinoma: a prospective, single-arm, phase II clinical study
Frontiers in Oncology
Original Research
Accepted on 11 Oct 2026
Pharmacist and Nurse Perceptions and Preferences for an On-Body Injector versus Manual Syringes for Large-Volume Subcutaneous Oncology and Haematology Biologic Preparation in the United Kingdom: A Cross-Sectional Survey
Frontiers in Oncology
Case Report
Accepted on 11 Oct 2026
Grade 3 cholestatic immune-related hepatitis under cemiplimab for high-risk locally advanced cutaneous squamous cell carcinoma – a case report from Germany
Frontiers in Oncology
Systematic Review
Accepted on 11 Oct 2026
Progressive multifocal leukoencephalopathy, bispecific antibodies and multiple myeloma: a case report and systematic review of the literature
Frontiers in Oncology
Original Research
Accepted on 11 Oct 2026
TMEM150C and F2R as transcriptomic signatures for refractoriness to 7+3 Induction therapy in Acute Myeloid Leukemia
Frontiers in Oncology
Case Report
Accepted on 10 Oct 2026
CK20/CK7 double-negative Merkel cell carcinoma arising within a previously photodynamic-therapy-treated actinic keratosis field: a case report
Frontiers in Oncology
Original Research
Accepted on 10 Oct 2026
A Study on the Temporal Network Characteristics of Early Post-Chemotherapy Core Symptoms in Colorectal Cancer Patients Based on Ecological Momentary Assessment
Frontiers in Oncology
Original Research
Accepted on 10 Oct 2026
MiRNA-1915-3p dysregulation characterizes aggressive CRBP1-expressing lung adenocarcinoma cells in vitro and in patient-derived tissues
Frontiers in Oncology
Review
Accepted on 10 Oct 2026
Decoding lipid metabolic reprogramming in pancreatic ductal adenocarcinoma: from tumor–microenvironment crosstalk to therapeutic resistance
Frontiers in Oncology
Original Research
Accepted on 10 Oct 2026
SPP1-associated Pathomics Features for Prognostic Modeling in Pancreatic Ductal Adenocarcinoma
Frontiers in Oncology
Case Report
Accepted on 10 Oct 2026
Anlotinib Combined with Chemotherapy in Metastatic Desmoplastic Small Round Cell Tumor: A Case Report
Frontiers in Oncology
Case Report
Accepted on 09 Oct 2026
Malignant Transformation of Intraductal Papillary Neoplasm of the Bile Duct Following Non-standardized Biliary-Enteric Drainage for Hepatolithiasis: Two Case Reports and Literature Review
Frontiers in Oncology
Original Research
Accepted on 09 Oct 2026
Association of Drainage Volume Decline Trajectories During the First 7 Postoperative Days With Persistent Seroma on Postoperative Day 30 After Modified Radical Mastectomy for Breast Cancer
Frontiers in Oncology
- 100 views